Serum hepatocyte growth factor is increased in Hashimoto's thyroiditis whether or not it is associated with nodular goiter as compared with healthy non-goitrous individuals

Journal of Endocrinological Investigation

Volumn 32, Issue 5, 2009, Pages 465-469

  Ruggeri, R M ^a   Sciacchitano, S ^b,c   Vitale, A ^b   Cardelli, P ^b   Galletti, M ^a   Vitarelli, E ^a   Barresi, G ^a   Benvenga, S ^a   Trimarchi, F ^a   Trovato, M ^a  

^a UNIVERSITY OF MESSINA   (Italy)

^b FATEBENEFRATELLI HOSPITAL   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Growth factors; Hashimoto's thyroiditis; Hepatocyte growth factor; Interleukin 6; Thyroid nodules

Indexed keywords

INTERLEUKIN 6; LEVOTHYROXINE; LIOTHYRONINE; SCATTER FACTOR; THYROTROPIN;

ADULT; AGED; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HASHIMOTO DISEASE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NODULAR GOITER; STATISTICAL SIGNIFICANCE; THYROID NODULE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; FEMALE; GOITER, NODULAR; HASHIMOTO DISEASE; HEALTH; HEPATOCYTE GROWTH FACTOR; HUMANS; INTERLEUKIN-6; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 70350302624     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03346487     Document Type: Article

References (31)

1. Benvenga S, Trimarchi F. Changed presentation of Hashimoto's thyroiditis in North-Eastern Sicily and Calabria (Southern Italy) based on a 31-year experience. Thyroid 2008, 18: 429-441
2. Weetman AP, McGregor AM. Autoimmune thyroid disease: further developments in our understanding. Endocr Rev 1994, 15: 788-830.
3. Gasbarri A, Sciacchitano S, Marasco A, et al. Detection and molecular characterization of thyroid cancer precursor lesions in a specific subset of Hashimoto's thyroiditis. Br J Cancer 2004, 91: 1096-1104 (Pubitemid 39336248)
4. Larson SD, Jackson LN, Riall TS, et al. Increased incidence of well- differentiated thyroid cancer associated with Hashimoto thyroiditis and the role of the PI3k/Akt pathway. J Am Coll Surg 2007, 204: 764-775
5. Repplinger D, Bargren A, Zhang YW, Adler JT, Haymart M, Chen H. Is Hashimoto's thyroiditis a risk factor for papillary thyroid cancer? J Surg Res 2008, 150: 49-52.
6. Intidhar Labidi S, Chaabouni AM, Kraiem T, et al. Thyroid carcinoma and Hashimoto thyroiditis. Ann Otolaryngol Chir Cervicofac 2006, 123: 175-178
7. Dumont JE, Lamy F, Roger P, Maenhaut C. Physiological and pathological regulation of thyroid cell proliferation and differentiation by thyrotropin and other factors. Physiol Rev 1992, 72: 667-697
8. Bidey SP, Hill DJ, Eggo MC. Growth factors and goitrogenesis. J Endocrinol 1999, 160: 321-332
9. Eggo MC, Quiney VM, Campbell S. Local factors regulating growth and function of human thyroid cells in vitro and in vivo. Mol Cell Endocrinol 2003, 213: 47-58. (Pubitemid 38229154)
10. Ruggeri RM, Sciacchitano S, Trimarchi F, Barresi G, Trovato M. Expression of hepatocyte growth factor in Hashimoto's thyroiditis with nodular lesions. Eur J Histochem 2007, 51: 193-198
11. Bottaro DP, Rubin JS, Faletto DL, et al. Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. Science 1991, 251: 802-804
12. Eccles N, Ivan M, Wynford-Thomas D. Mitogenic stimulation of normal and oncogene transformed human thyroid epithelial cells by hepatocyte growth factor. Mol Cell Endocrinol 1996, 117: 247-251 (Pubitemid 26118942)
13. Trovato M, Villari D, Bartolone L, et al. Expression of the hepatocyte growth factor and c-met in normal thyroid, non-neoplastic, and neoplastic nodules. Thyroid 1998, 8: 125-131 (Pubitemid 28103599)
14. Trovato M, Grosso M, Vitarelli E, et al. Distinctive expression of STAT3 in papillary thyroid carcinomas and a subset of follicular adenomas. Histol Histopathol 2003, 18: 393-399 (Pubitemid 36362056)
15. Scarpino S, D'Alena FC, Di Napoli A, Ballarini F, Prat M, Ruco LP. Papillary carcinoma of the thyroid: evidence for a role for hepatocyte growth factor (HGF) in promoting tumour angiogenesis. J Pathol 2003, 199: 243-250 (Pubitemid 36176031)
16. Mineo R, Costantino A, Frasca F, et al. Activation of the hepatocyte growth factor (HGF)-Met system in papillary thyroid cancer: biological effects of HGF in thyroid cancer cells depend on Met expression levels. Endocrinology 2004, 145: 4355-4365 (Pubitemid 39120585)
17. Vesely D, Astl J, Lastuvka P, Matucha P, Sterzl I, Betka J. Serum levels of IGF-I, HGF, TGFbeta1, bFGF and VEGF in thyroid gland tumors. Physiol Res 2004, 53: 83-89 (Pubitemid 38295545)
18. Hirano T. Interleukin 6 and its receptor: ten years later. Int Rev Immunol 1998, 16: 249-284 (Pubitemid 28102256)
19. Zheng RQ, Abney E, Chu CQ, et al. Detection of interleukin-6 and interleukin-1 production in human thyroid epithelial cells by non-radioactive in situ hybridization and immunohistochemical methods. Clin Exp Immunol 1991, 83: 314-319
20. Kayser L, Broholm H, Francis D, et al. Immunocytochemical localization of interleukin-1 alpha and interleukin-6 in thyroid tissues from patients with neoplastic or autoimmune thyroid disorders. Autoimmunity 1995, 20: 75-82.
21. Basolo F, Fiore L, Pollina L, Fontanini G, Conaldi PG, Toniolo A. Reduced expression of interleukin 6 in undifferentiated thyroid carcinoma: in vitro and in vivo studies. Clin Cancer Res 1998, 4: 381-387 (Pubitemid 28122753)
22. Ruggeri RM, Villari D, Simone A, et al. Co-expression of interleukin- 6 (IL-6) and interleukin-6 receptor (IL-6R) in thyroid nodules is associated with co-expression of CD30 ligand/CD30 receptor. J Endocrinol Invest 2002, 25: 959-966 (Pubitemid 36113280)
23. Ruggeri RM, Barresi G, Sciacchitano S, Trimarchi F, Benvenga S, Trovato M. Immunoexpression of the CD30 Ligand/CD30 and IL- 6/IL-6R signals in thyroid autoimmune diseases. Histol Histopathol 2006, 21: 249-256 (Pubitemid 43033734)
24. Papanas N, Papazoglou D, Papatheodorou K, Antonoglou C, Kotsiou S, Maltezos E. Thyroxine replacement dose in patients with Hashimoto's disease: a potential role for interleukin-6. Cytokine 2006, 35: 166-170 (Pubitemid 44666433)
25. Studer H, Gerber H, Zbaeren J, Peter HJ. Histomorphological and immunohistochemical evidence that human nodular goiters grow by episodic replication of multiple clusters of thyroid follicular cells. J Clin Endocrinol Metab 1992, 75: 1151-1158
26. Studer H, Derwahl M. Mechanisms of nonneoplastic endocrine hyperplasia - a changing concept: a review focused on the thyroid gland. Endocr Rev 1995, 16: 411-426
27. Kimura T, Van Keymeulen A, Golstein J, Fusco A, Dumont JE, Roger PP. Regulation of thyroid cell proliferation by TSH and other factors: a critical evaluation of in vitro models. Endocr Rev 2001, 22: 631-656 (Pubitemid 32955247)
28. Vannelli GB, Barni T, Modigliani U, et al. Insulin-like growth factor- I receptors in nonfunctioning thyroid nodules. J Clin Endocrinol Metab 1990, 71: 1175-1182 (Pubitemid 20386315)
29. Gärtner R, Veitenhansl M, Aktas J, Schopohl D. Role of basic fibroblast growth factor in the pathogenesis of nodular goiter. Exp Clin Endocrinol Diabetes 1996, 104 (Suppl): 36-38 (Pubitemid 26418396)
30. Thompson SD, Franklyn JA, Watkinson JC, Verhaeg JM, Sheppard MC, Eggo MC. Fibroblast growth factors 1 and 2 and fibroblast growth factor receptor 1 are elevated in thyroid hyperplasia. J Clin Endocrinol Metab 1998, 83: 1336-1341 (Pubitemid 28496417)
31. Kimura ET, Kopp P, Zbaeren J, et al. Expression of transforming growth factor beta1, beta2, and beta3 in multinodular goiters and differentiated thyroid carcinomas: a comparative study. Thyroid 1999, 9: 119-125